New Indication: Tazemetostat for relapsed/refractory follicular lymphoma
|New Indication: Tazemetostat for relapsed/refractory follicular lymphoma|
Lancet Oncology 2020 Oct 6. Online ahead of print.
Morschhauser F, et al. Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial.https://doi.org/10.1016/S1470-2045(20)30441-1
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.